1. Home
  2. NMM vs AAPG Comparison

NMM vs AAPG Comparison

Compare NMM & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navios Maritime Partners LP

NMM

Navios Maritime Partners LP

HOLD

Current Price

$81.35

Market Cap

2.1B

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$17.68

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMM
AAPG
Founded
2007
2009
Country
Greece
China
Employees
N/A
767
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
NMM
AAPG
Price
$81.35
$17.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$85.00
$48.40
AVG Volume (30 Days)
93.1K
4.8K
Earning Date
05-05-2026
05-20-2026
Dividend Yield
0.34%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.57
$290.34
Revenue Next Year
$3.66
N/A
P/E Ratio
$7.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.66
$16.36
52 Week High
$80.97
$48.45

Technical Indicators

Market Signals
Indicator
NMM
AAPG
Relative Strength Index (RSI) 64.12 40.91
Support Level $69.21 $16.64
Resistance Level $80.69 $18.17
Average True Range (ATR) 2.50 0.41
MACD 0.53 -0.16
Stochastic Oscillator 79.97 3.83

Price Performance

Historical Comparison
NMM
AAPG

About NMM Navios Maritime Partners LP

Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: